April 1, 2013
An interpretive statement concerning BOTOX® and dermal fillers has received early approval of the Dental Quality Assurance Commission (DQAC). Such guidance has been requested by dentists in recent years. The final interpretive statement is expected later this year after the formal review process is completed by the Department of Health.
The analysis of the statement concludes that dentists with “appropriate, verifiable training and experience” should have a scope of practice which can include use of BOTOX® and dermal fillers “in the soft tissues throughout the face” in order “to treat functional or esthetic dental conditions and their direct esthetic consequences …” The analysis is based on the education of dentists in “functional aspects and resulting esthetic ramifications of dental conditions and dental treatment.”
The statement distinguishes the above use BOTOX® and dermal fillers from their use for “strictly the esthetic correction of fine lines and furrowing that results in the skin from the muscles of facial expression.”
According to the guidance, use of the materials “outside the treatment of dental related conditions for purely cosmetic purposes” should not be in the scope of practice of dentists unless trained as an oral and maxillofacial surgeon.
Dentists who expect to provide such services may want to review the statement. Although the statement is not yet final, draft text of it is available at www.wsda.org/dqac/.
Also remember – Provisions of such services is a good time to review your insurance. Your company may offer an endorsement covering such services which should be added to the policy.
Please email Alan Wicks, WSDA General Counsel at email@example.com if you have additional questions.